ECTRIMS 2024 Insights: Pathology of NMOSD, MOGAD and MS

Hans Lassmann

Effectiveness of Tixagevimab/Cilgavimab (Evusheld) in AntiCD20-Treat…

Dominika Stastna

NMOSD and MOGAD Clinical Trials

Siegel Rare Neuroimmune Association

M. Levy

ECTRIMS 2024 Insights: Clinical Spectrum of MOG Antibody-Associated …

Kazuo Fujihara

Management of Neuromyelitis Optica Spectrum Disorders (NMOSD) in 2022

University of Miami

L. Tornes

The Role of Optical Coherence Tomography in Neurology

University of Miami

H. Jiang

Optical Coherence Tomography (OCT) in Neuromyelitis Optica Spectrum …

University of Miami

H. Jiang

Imaging Features of MOGAD and Key Flags

Giulia Fadda

Anti-C5 Complement Therapy in NMO: Eculizumab and Ravulizumab

University of Miami

F. Nelson

The Current Spectrum of NMOSD

Olga Rosenvald Thon

Diagnostic Criteria for Myelin Oligodendrocyte Glycoprotein Antibody…

Cleveland Clinic Neurological Institute

J. R. Abbatemarco

Neuroimaging Case Studies in Inflammation and Demyelination

2023 Conference Coverage

U. Kaunzner

Immune Checkpoint Inhibitors and Neurological Adverse Events

Cleveland Clinic Neurological Institute

A. Kunchok

Everything a Neurologist Needs to Know About NMO & MOG

University of Miami

M. Levy

IL6 Receptor Inhibition in Treatment of NMOSD

University of Miami

K. Rammohan

Neuromyelitis Optica: Acute and Preventative Treatments in the Era o…

Bruce Cree

Update in Autoimmune Neurology & Neuroimmunology

Justin R. Abbatemarco

Iatrogenic CNS Inflammation in the Era of Modern Biologics

University Hospitals

H. Abboud

Cases of Caution in Inpatient Neuroimmunology: When the First Diagno…

Northwestern Medicine Neurology and Neurosurgery

E. Graham

MOG Antibody Disease (MOGAD) Update

University of Miami

M. Ortega